Evidence map›Paper›PMID 35055120›Full record

ArticleInternational journal of molecular sciences2022

Theranostic Platforms Based on Silica and Magnetic Nanoparticles Containing Quinacrine, Chitosan, Fluorophores, and Quantum Dots.

Dmitry V Korolev, Galina A Shulmeyster, Natalia V Evreinova, Maria S Syrovatkina, Maria S Istomina, Victor N Postnov, Ilia V Aleksandrov, Aleksandr S Krasichkov, Michael M Galagudza

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in International journal of molecular sciences, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Dmitry V KorolevInstitute of Experimental Medicine, Almazov National Medical Research Centre, 2 Akkuratova Str., 197341 Saint Petersburg, Russia.
Galina A ShulmeysterInstitute of Experimental Medicine, Almazov National Medical Research Centre, 2 Akkuratova Str., 197341 Saint Petersburg, Russia.
Natalia V EvreinovaInstitute of Experimental Medicine, Almazov National Medical Research Centre, 2 Akkuratova Str., 197341 Saint Petersburg, Russia.
Maria S SyrovatkinaDepartment of Micro- and Nanoelectronics, Saint Petersburg Electrotechnical University "LETI", 5 Professora Popova Street, 197376 Saint Petersburg, Russia.
Maria S IstominaInstitute of Experimental Medicine, Almazov National Medical Research Centre, 2 Akkuratova Str., 197341 Saint Petersburg, Russia.
Victor N PostnovInstitute of Experimental Medicine, Almazov National Medical Research Centre, 2 Akkuratova Str., 197341 Saint Petersburg, Russia.
Ilia V AleksandrovInstitute of Experimental Medicine, Almazov National Medical Research Centre, 2 Akkuratova Str., 197341 Saint Petersburg, Russia.ORCID 0000-0001-8286-8070
Aleksandr S KrasichkovDepartment of Radio Engineering Systems, Saint Petersburg Electrotechnical University "LETI", 5 Professora Popova Street, 197376 Saint Petersburg, Russia.
Michael M GalagudzaInstitute of Experimental Medicine, Almazov National Medical Research Centre, 2 Akkuratova Str., 197341 Saint Petersburg, Russia.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In this paper, we describe the synthesis of multilayer nanoparticles as a platform for the diagnosis and treatment of ischemic injuries. The platform is based on magnetite (MNP) and silica (SNP) nanoparticles, while quinacrine is used as an anti-ischemic agent. The synthesis includes the surface modification of nanoparticles with (3-glycidyloxypropyl)trimethoxysilane (GPMS), the immobilization of quinacrine, and the formation of a chitosan coating, which is used to fix the fluorophore indocyanine green (ICG) and colloidal quantum dots AgInS

Indexed as

ChitosanEarly DiagnosisFluorescent DyesHumansIschemiaMagnetite NanoparticlesMolecular StructureNanoparticlesPrecision MedicineQuantum DotsQuinacrineSilicon DioxideTheranostic NanomedicineChitosanFluorescent DyesMagnetite NanoparticlesQuinacrineSilicon Dioxidechitosancolloidal quantum dotsindocyanine greenmagnetic nanoparticlesmultilayer nanoparticlesquinacrinesilica nanoparticlestheranostics

Identifiers

PMID35055120
PMCPMC8779983

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.